BMI1 and chronic myelogenous leukemia, BCR-ABL1 positive: The expression of BMI1/PCGF4 has correlated with disease progression and the prognosis of myelodysplastic syndrome (MDS) [23], the prognoses of acute myeloid leukemia (AML) and chronic myeloid leukemia [24].